Novartis AG vs Royal Bank of Canada
Novartis AG is worth $299.439B, 1.0× the $287.952B market cap of Royal Bank of Canada. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $299.439B | $287.952B |
| Global rank | #1 | #2 |
| Share price | $157.54 | $207.21 |
| Change | +1.90% | -1.45% |
| Revenue | $56.674B | $46.873B |
| Net income | $13.984B | $14.345B |
| Country | Switzerland | Canada |
| Sector | Healthcare | Financial Services |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Novartis AG bigger than Royal Bank of Canada?
- Novartis AG has a market cap of $299.439B against $287.952B for Royal Bank of Canada, making it 1.0 times as valuable.
- Which company earns more, NVS or RY?
- Novartis AG reported net income of $13.984B and Royal Bank of Canada reported $14.345B in their most recent annual periods.